CLOZAPINE - DECIPHERING THE RISKS

被引：48

作者：

GERSON, SL

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1993年 / 329卷 / 03期

关键词：

D O I：

10.1056/NEJM199307153290312

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：204 / 205

页数：2

共 11 条

[1] CLOZAPINE-INDUCED AGRANULOCYTOSIS - INCIDENCE AND RISK-FACTORS IN THE UNITED-STATES [J].

ALVIR, JMJ ;

LIEBERMAN, JA ;

SAFFERMAN, AZ ;

SCHWIMMER, JL ;

SCHAAF, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) :162-167

[2]

BANOV MD, IN PRESS J CLIN PSYC

[3] GRANULOCYTE COLONY-STIMULATING FACTOR FOR CLOZAPINE-INDUCED AGRANULOCYTOSIS [J].

GERSON, SL ;

GULLION, G ;

YEH, HS ;

MASOR, C .

LANCET, 1992, 340 (8827) :1097-1097

[4]

GERSON SL, 1991, BLOOD S, V78, pA417

[5]

Mason R P, 1992, Drug Saf, V7 Suppl 1, P45

[6]

PISCIOTTA AV, 1992, J LAB CLIN MED, V119, P254

[7]

PIZZO PA, 1993, NEW ENGL J MED, V328, P1323

[8] RECHALLENGE IN CLOZAPINE-INDUCED AGRANULOCYTOSIS [J].

SAFFERMAN, AZ ;

LIEBERMAN, JA ;

ALVIR, JMJ ;

HOWARD, A .

LANCET, 1992, 339 (8804) :1296-1297

[9] MANDATORY MONITORING FOR SIDE-EFFECTS - THE BUNDLING OF CLOZAPINE [J].

SALZMAN, C .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (12) :827-829

[10]

Uetrecht J P, 1992, Drug Saf, V7 Suppl 1, P51

← 1 2 →